<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="alter">
            <roleset id="alter.01" name="" wordnet="1">
                <roles>
                    <role n="0" descr="causer of transformation&#x09;&#x09;// mutation, protein //&#x0A;" />
                    <role n="1" descr="thing changing&#x09;&#x09;&#x09;&#x09;// codon, exon, premRNA //&#x0A;" />
                    <role n="2" descr="end state&#x09;&#x09;&#x09;&#x09;&#x0A;" />
                    <role n="3" descr="start state&#x09;&#x09;&#x09;&#x09;&#x0A;" />
                    <role n="4" descr="location refering to tissue, organelle, person, gene&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>Cytokines altered the expression and activity of the multidrug resistance transporters in human hepatoma cell lines; analysis using RT-PCR and cDNA microarrays.</text>
                    <arg n="0">Cytokines</arg>
                    <arg n="1">the expression and activity of the multidrug resistance transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="EGRAM" no="1">
                    <text>Cytokines are able to alter the expression and activity of the multidrug resistance transporters in human hepatoma cell lines; analysis using RT-PCR and cDNA microarrays.</text>
                    <arg n="0">Cytokines</arg>
                    <arg n="1">the expression and activity of the multidrug resistance transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="EGRAM" no="2">
                    <text>Cytokines can alter the expression and activity of the multidrug resistance transporters in human hepatoma cell lines; analysis using RT-PCR and cDNA microarrays.</text>
                    <arg n="0">Cytokines</arg>
                    <arg n="1">the expression and activity of the multidrug resistance transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="EGRAM" no="3">
                    <text>Cytokines have the ability to alter the expression and activity of the multidrug resistance transporters in human hepatoma cell lines; analysis using RT-PCR and cDNA microarrays.</text>
                    <arg n="0">Cytokines</arg>
                    <arg n="1">the expression and activity of the multidrug resistance transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>Cytokines may alter the expression and activity of the multidrug resistance transporters in human hepatoma cell lines; analysis using RT-PCR and cDNA microarrays.</text>
                    <arg n="0">Cytokines</arg>
                    <arg n="1">the expression and activity of the multidrug resistance transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="EGRAM" no="5">
                    <text>Either the conserved gt or ag dinucleotide splice sites could be altered by four other mutations in the IVD gene.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="EGRAM" no="6">
                    <text>Either the conserved gt or ag dinucleotide splice sites is altered by four other mutations in the IVD gene.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="EGRAM" no="7">
                    <text>Either the conserved gt or ag dinucleotide splice sites may be altered by four other mutations in the IVD gene.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="EGRAM" no="8">
                    <text>Either the conserved gt or ag dinucleotide splice sites was altered by four other mutations in the IVD gene.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="EGRAM" no="9">
                    <text>Four other mutations altered either the conserved gt or ag dinucleotide splice sites in the IVD gene.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="EGRAM" no="10">
                    <text>Four other mutations are able to alter either the conserved gt or ag dinucleotide splice sites in the IVD gene.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="EGRAM" no="11">
                    <text>Four other mutations can alter either the conserved gt or ag dinucleotide splice sites in the IVD gene.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="EGRAM" no="12">
                    <text>Four other mutations may alter either the conserved gt or ag dinucleotide splice sites in the IVD gene.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="EGRAM" no="13">
                    <text>Four other mutations were able to alter either the conserved gt or ag dinucleotide splice sites in the IVD gene.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="EGRAM" no="14">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the specific protein DNA interactions observed are able to be altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="EGRAM" no="15">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the specific protein DNA interactions observed can be altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="EGRAM" no="16">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the specific protein DNA interactions observed could be altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="EGRAM" no="17">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the specific protein DNA interactions observed is altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the specific protein DNA interactions observed may be altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="EGRAM" no="19">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the specific protein DNA interactions observed was altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="EGRAM" no="20">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because the change in DNA conformation can subtly alter the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="EGRAM" no="21">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because the change in DNA conformation is able to subtly alter the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="EGRAM" no="22">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because the change in DNA conformation may be able to subtly alter the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="EGRAM" no="23">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because the change in DNA conformation may subtly alter the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="EGRAM" no="24">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because the change in DNA conformation subtly altered the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="EGRAM" no="25">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because the change in DNA conformation subtly alters the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="EGRAM" no="26">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to the change in DNA conformation, which can subtly alter the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="EGRAM" no="27">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to the change in DNA conformation, which is able to subtly alter the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="EGRAM" no="28">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to the change in DNA conformation, which may be able to subtly alter the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="EGRAM" no="29">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to the change in DNA conformation, which may subtly alter the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="EGRAM" no="30">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to the change in DNA conformation, which subtly altered the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="EGRAM" no="31">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to the change in DNA conformation, which was able to subtly alter the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="EGRAM" no="32">
                    <text>In protein-coding transcripts, 79% of splice variations alter the protein product. Whole-transcriptome analyses resulted in the identification of 2,431 sense-antisense pairs.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="EGRAM" no="33">
                    <text>In protein-coding transcripts, 79% of splice variations are able to alter the protein product. Whole-transcriptome analyses resulted in the identification of 2,431 sense-antisense pairs.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="EGRAM" no="34">
                    <text>In protein-coding transcripts, 79% of splice variations can alter the protein product. Whole-transcriptome analyses resulted in the identification of 2,431 sense-antisense pairs.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="EGRAM" no="35">
                    <text>In protein-coding transcripts, 79% of splice variations could alter the protein product. Whole-transcriptome analyses resulted in the identification of 2,431 sense-antisense pairs.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="EGRAM" no="36">
                    <text>In protein-coding transcripts, 79% of splice variations may alter the protein product. Whole-transcriptome analyses resulted in the identification of 2,431 sense-antisense pairs.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="EGRAM" no="37">
                    <text>In protein-coding transcripts, 79% of splice variations will alter the protein product. Whole-transcriptome analyses resulted in the identification of 2,431 sense-antisense pairs.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="EGRAM" no="38">
                    <text>In protein-coding transcripts, the protein product can be altered by 79% of splice variations. Whole-transcriptome analyses resulted in the identification of 2,431 sense-antisense pairs.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="EGRAM" no="39">
                    <text>In protein-coding transcripts, the protein product could be altered by 79% of splice variations. Whole-transcriptome analyses resulted in the identification of 2,431 sense-antisense pairs.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="EGRAM" no="40">
                    <text>In protein-coding transcripts, the protein product is able to be altered by 79% of splice variations. Whole-transcriptome analyses resulted in the identification of 2,431 sense-antisense pairs.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="EGRAM" no="41">
                    <text>In protein-coding transcripts, the protein product is altered by 79% of splice variations. Whole-transcriptome analyses resulted in the identification of 2,431 sense-antisense pairs.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>In protein-coding transcripts, the protein product may be altered by 79% of splice variations. Whole-transcriptome analyses resulted in the identification of 2,431 sense-antisense pairs.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="EGRAM" no="43">
                    <text>In protein-coding transcripts, the protein product was altered by 79% of splice variations. Whole-transcriptome analyses resulted in the identification of 2,431 sense-antisense pairs.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="EGRAM" no="44">
                    <text>In protein-coding transcripts, the protein product will be altered by 79% of splice variations. Whole-transcriptome analyses resulted in the identification of 2,431 sense-antisense pairs.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="EGRAM" no="45">
                    <text>It is believed that the molecular lesion associated with s1031 is able to alter splicing, we looked at the sos-1 mRNA produced in this mutant.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="EGRAM" no="46">
                    <text>It is predicted that the molecular lesion associated with s1031 can alter splicing, we looked at the sos-1 mRNA produced in this mutant.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="EGRAM" no="47">
                    <text>Moreover, Dam methylation inhibited binding of Lrp/PapI near the GATC1028 site and altered binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="EGRAM" no="48">
                    <text>Moreover, Dam methylation inhibited binding of Lrp/PapI near the GATC1028 site and could alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="EGRAM" no="49">
                    <text>Moreover, Dam methylation inhibited binding of Lrp/PapI near the GATC1028 site and has altered binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="EGRAM" no="50">
                    <text>Moreover, Dam methylation inhibited binding of Lrp/PapI near the GATC1028 site and was able to alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="EGRAM" no="51">
                    <text>Moreover, Dam methylation inhibited binding of Lrp/PapI near the GATC1028 site and would alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="EGRAM" no="52">
                    <text>Moreover, Dam methylation inhibits binding of Lrp/PapI near the GATC1028 site and can alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="EGRAM" no="53">
                    <text>Moreover, Dam methylation inhibits binding of Lrp/PapI near the GATC1028 site and is able to alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="EGRAM" no="54">
                    <text>Moreover, Dam methylation inhibits binding of Lrp/PapI near the GATC1028 site and may alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="EGRAM" no="55">
                    <text>Moreover, Dam methylation inhibits binding of Lrp/PapI near the GATC1028 site and will alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="EGRAM" no="56">
                    <text>Moreover, a fruR null mutation alters the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="EGRAM" no="57">
                    <text>Moreover, a fruR null mutation can alter the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="EGRAM" no="58">
                    <text>Moreover, a fruR null mutation could alter the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="EGRAM" no="59">
                    <text>Moreover, a fruR null mutation has altered the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="EGRAM" no="60">
                    <text>Moreover, a fruR null mutation is able to alter the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="EGRAM" no="61">
                    <text>Moreover, a fruR null mutation may alter the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="EGRAM" no="62">
                    <text>Moreover, a fruR null mutation may be able to alter the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="EGRAM" no="63">
                    <text>Moreover, a fruR null mutation will alter the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="EGRAM" no="64">
                    <text>Moreover, a fruR null mutation will be able to alter the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="EGRAM" no="65">
                    <text>Mutations altering splice sites led to the synthesis of several types of mRNAs, a fraction of which represented the normally spliced product.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">splice sites</arg>
                </example>
                <example src="EGRAM" no="66">
                    <text>Mutations being able to alter splice sites led to the synthesis of several types of mRNAs, a fraction of which represented the normally spliced product.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">splice sites</arg>
                </example>
                <example src="EGRAM" no="67">
                    <text>Mutations that altered splice sites led to the synthesis of several types of mRNAs, a fraction of which represented the normally spliced product.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">splice sites</arg>
                </example>
                <example src="EGRAM" no="68">
                    <text>Mutations that are able to alter splice sites led to the synthesis of several types of mRNAs, a fraction of which represented the normally spliced product.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">splice sites</arg>
                </example>
                <example src="EGRAM" no="69">
                    <text>Mutations that can alter splice sites led to the synthesis of several types of mRNAs, a fraction of which represented the normally spliced product.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">splice sites</arg>
                </example>
                <example src="EGRAM" no="70">
                    <text>Mutations which are able to prevent repressor binding to either site or to alter the phasing of the binding sites result in simultaneous derepression of both genes.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="EGRAM" no="71">
                    <text>Mutations which has prevented repressor binding to either site or has altered the phasing of the binding sites result in simultaneous derepression of both genes.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="EGRAM" no="72">
                    <text>Mutations which prevented repressor binding to either site or altered the phasing of the binding sites result in simultaneous derepression of both genes.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="EGRAM" no="73">
                    <text>Phosphorylation of PDK1 cannot be altered by treating the cells with insulin-like growth factor-I and four of the sites could be mutated without loss of activity.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="74">
                    <text>Phosphorylation of PDK1 is not able to be altered by treating the cells with insulin-like growth factor-I and four of the sites could be mutated without loss of activity.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="75">
                    <text>Phosphorylation of PDK1 is not altered by treating the cells with insulin-like growth factor-I and four of the sites could be mutated without loss of activity.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="76">
                    <text>Phosphorylation of PDK1 will not be altered by treating the cells with insulin-like growth factor-I and four of the sites could be mutated without loss of activity.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="77">
                    <text>Since s1031 is a null allele, we are testing whether this mutation can alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="EGRAM" no="78">
                    <text>Since s1031 is a null allele, we are testing whether this mutation is able to alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="EGRAM" no="79">
                    <text>Since s1031 is a null allele, we are testing whether this mutation is going to alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="EGRAM" no="80">
                    <text>Since s1031 is a null allele, we are testing whether this mutation may alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="EGRAM" no="81">
                    <text>Since s1031 is a null allele, we are testing whether this mutation will alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="EGRAM" no="82">
                    <text>Since s1031 is a null allele, we are testing whether vulval induction can be altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="EGRAM" no="83">
                    <text>Since s1031 is a null allele, we are testing whether vulval induction is able to be altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="EGRAM" no="84">
                    <text>Since s1031 is a null allele, we are testing whether vulval induction is altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="EGRAM" no="85">
                    <text>Since s1031 is a null allele, we are testing whether vulval induction may be altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="EGRAM" no="86">
                    <text>Since s1031 is a null allele, we tested whether this mutation altered vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="EGRAM" no="87">
                    <text>Since s1031 is a null allele, we tested whether this mutation could alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="EGRAM" no="88">
                    <text>Since s1031 is a null allele, we tested whether this mutation has altered vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="EGRAM" no="89">
                    <text>Since s1031 is a null allele, we tested whether this mutation might alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="EGRAM" no="90">
                    <text>Since s1031 is a null allele, we tested whether this mutation was able to alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="EGRAM" no="91">
                    <text>Since s1031 is a null allele, we tested whether vulval induction could be altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="EGRAM" no="92">
                    <text>Since s1031 is a null allele, we tested whether vulval induction might be altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="EGRAM" no="93">
                    <text>Since s1031 is a null allele, we tested whether vulval induction was able to be altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="EGRAM" no="94">
                    <text>Since s1031 is a null allele, we tested whether vulval induction was altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="EGRAM" no="95">
                    <text>Since these two bends are in opposing directions, the overall direction of the DNA cannot be altered by them(Figure 3C).</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="96">
                    <text>Since these two bends are in opposing directions, the overall direction of the DNA is not able to be altered by them(Figure 3C).</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="97">
                    <text>Since these two bends are in opposing directions, the overall direction of the DNA is not altered by them(Figure 3C).</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="98">
                    <text>Since these two bends are in opposing directions, the overall direction of the DNA may not be altered by them(Figure 3C).</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="99">
                    <text>Since these two bends are in opposing directions, the overall direction of the DNA will not be altered by them(Figure 3C).</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="100">
                    <text>Since these two bends are in opposing directions, they are not able to alter the overall direction of the DNA(Figure 3C).</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="101">
                    <text>Since these two bends are in opposing directions, they cannot alter the overall direction of the DNA(Figure 3C).</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="102">
                    <text>Since these two bends are in opposing directions, they may not alter the overall direction of the DNA(Figure 3C).</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="103">
                    <text>Since these two bends are in opposing directions, they will not alter the overall direction of the DNA(Figure 3C).</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="104">
                    <text>Since these two bends were in opposing directions, the overall direction of the DNA could not be altered by them(Figure 3C).</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="105">
                    <text>Since these two bends were in opposing directions, the overall direction of the DNA was not able to be altered by them(Figure 3C).</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="106">
                    <text>Since these two bends were in opposing directions, the overall direction of the DNA was not altered by them(Figure 3C).</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="107">
                    <text>Since these two bends were in opposing directions, they could not alter the overall direction of the DNA(Figure 3C).</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="108">
                    <text>Since these two bends were in opposing directions, they did not alter the overall direction of the DNA(Figure 3C).</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="109">
                    <text>Since these two bends were in opposing directions, they were not able to alter the overall direction of the DNA(Figure 3C).</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="110">
                    <text>Splice sites are able to be altered by mutations leading to the synthesis of several types of mRNAs, a fraction of which represented the normally spliced product.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">splice sites</arg>
                </example>
                <example src="EGRAM" no="111">
                    <text>Splice sites are altered by mutations leading to the synthesis of several types of mRNAs, a fraction of which represented the normally spliced product.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">splice sites</arg>
                </example>
                <example src="EGRAM" no="112">
                    <text>Splice sites can be altered by mutations leading to the synthesis of several types of mRNAs, a fraction of which represented the normally spliced product.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">splice sites</arg>
                </example>
                <example src="EGRAM" no="113">
                    <text>Splice sites could be altered by mutations leading to the synthesis of several types of mRNAs, a fraction of which represented the normally spliced product.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">splice sites</arg>
                </example>
                <example src="EGRAM" no="114">
                    <text>Splice sites may be altered by mutations leading to the synthesis of several types of mRNAs, a fraction of which represented the normally spliced product.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">splice sites</arg>
                </example>
                <example src="EGRAM" no="115">
                    <text>Splice sites might be altered by mutations leading to the synthesis of several types of mRNAs, a fraction of which represented the normally spliced product.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">splice sites</arg>
                </example>
                <example src="EGRAM" no="116">
                    <text>Splice sites were able to be altered by mutations leading to the synthesis of several types of mRNAs, a fraction of which represented the normally spliced product.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">splice sites</arg>
                </example>
                <example src="EGRAM" no="117">
                    <text>Splice sites were altered by mutations leading to the synthesis of several types of mRNAs, a fraction of which represented the normally spliced product.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">splice sites</arg>
                </example>
                <example src="EGRAM" no="118">
                    <text>Splice sites will be altered by mutations leading to the synthesis of several types of mRNAs, a fraction of which represented the normally spliced product.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">splice sites</arg>
                </example>
                <example src="EGRAM" no="119">
                    <text>Splicing can be altered by the molecular lesion associated with s1031, we looked at the sos-1 mRNA produced in this mutant.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="EGRAM" no="120">
                    <text>Splicing is able to be altered by the molecular lesion associated with s1031, we looked at the sos-1 mRNA produced in this mutant.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="EGRAM" no="121">
                    <text>Splicing is predicted to be altered by the molecular lesion associated with s1031, we looked at the sos-1 mRNA produced in this mutant.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="EGRAM" no="122">
                    <text>Splicing may be altered by the molecular lesion associated with s1031, we looked at the sos-1 mRNA produced in this mutant.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="EGRAM" no="123">
                    <text>Splicing will be altered by the molecular lesion associated with s1031, we looked at the sos-1 mRNA produced in this mutant.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="EGRAM" no="124">
                    <text>The codon (CTC) normally associated with Leu-93 in the transcortin polypeptide can be altered by the mutation located within exon 2 to a codon (CAC) for histidine in the variant genes.</text>
                    <arg n="0">the mutation located within exon 2</arg>
                    <arg n="1">the codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                    <arg n="3">the codon (CTC)</arg>
                </example>
                <example src="EGRAM" no="125">
                    <text>The codon (CTC) normally associated with Leu-93 in the transcortin polypeptide is able to be altered by the mutation located within exon 2 to a codon (CAC) for histidine in the variant genes.</text>
                    <arg n="0">the mutation located within exon 2</arg>
                    <arg n="1">the codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                    <arg n="3">the codon (CTC)</arg>
                </example>
                <example src="EGRAM" no="126">
                    <text>The codon (CTC) normally associated with Leu-93 in the transcortin polypeptide is altered by the mutation located within exon 2 to a codon (CAC) for histidine in the variant genes.</text>
                    <arg n="0">the mutation located within exon 2</arg>
                    <arg n="1">the codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                    <arg n="3">the codon (CTC)</arg>
                </example>
                <example src="EGRAM" no="127">
                    <text>The codon (CTC) normally associated with Leu-93 in the transcortin polypeptide may be altered by the mutation located within exon 2 to a codon (CAC) for histidine in the variant genes.</text>
                    <arg n="0">the mutation located within exon 2</arg>
                    <arg n="1">the codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                    <arg n="3">the codon (CTC)</arg>
                </example>
                <example src="EGRAM" no="128">
                    <text>The codon (CTC) normally associated with Leu-93 in the transcortin polypeptide will be altered by the mutation located within exon 2 to a codon (CAC) for histidine in the variant genes.</text>
                    <arg n="0">the mutation located within exon 2</arg>
                    <arg n="1">the codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                    <arg n="3">the codon (CTC)</arg>
                </example>
                <example src="EGRAM" no="129">
                    <text>The expression and activity of the multidrug resistance transporters can be altered by Cytokines in human hepatoma cell lines; analysis using RT-PCR and cDNA microarrays.</text>
                    <arg n="0">Cytokines</arg>
                    <arg n="1">the expression and activity of the multidrug resistance transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="EGRAM" no="130">
                    <text>The expression and activity of the multidrug resistance transporters could be altered by Cytokines in human hepatoma cell lines; analysis using RT-PCR and cDNA microarrays.</text>
                    <arg n="0">Cytokines</arg>
                    <arg n="1">the expression and activity of the multidrug resistance transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="EGRAM" no="131">
                    <text>The expression and activity of the multidrug resistance transporters is able to be altered by Cytokines in human hepatoma cell lines; analysis using RT-PCR and cDNA microarrays.</text>
                    <arg n="0">Cytokines</arg>
                    <arg n="1">the expression and activity of the multidrug resistance transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="EGRAM" no="132">
                    <text>The expression and activity of the multidrug resistance transporters is altered by Cytokines in human hepatoma cell lines; analysis using RT-PCR and cDNA microarrays.</text>
                    <arg n="0">Cytokines</arg>
                    <arg n="1">the expression and activity of the multidrug resistance transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="EGRAM" no="133">
                    <text>The expression and activity of the multidrug resistance transporters may be altered by Cytokines in human hepatoma cell lines; analysis using RT-PCR and cDNA microarrays.</text>
                    <arg n="0">Cytokines</arg>
                    <arg n="1">the expression and activity of the multidrug resistance transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="EGRAM" no="134">
                    <text>The expression and activity of the multidrug resistance transporters was able to be altered by Cytokines in human hepatoma cell lines; analysis using RT-PCR and cDNA microarrays.</text>
                    <arg n="0">Cytokines</arg>
                    <arg n="1">the expression and activity of the multidrug resistance transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="EGRAM" no="135">
                    <text>The expression and activity of the multidrug resistance transporters was altered by Cytokines in human hepatoma cell lines; analysis using RT-PCR and cDNA microarrays.</text>
                    <arg n="0">Cytokines</arg>
                    <arg n="1">the expression and activity of the multidrug resistance transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="EGRAM" no="136">
                    <text>The expression and activity of the multidrug resistance transporters will be altered by Cytokines in human hepatoma cell lines; analysis using RT-PCR and cDNA microarrays.</text>
                    <arg n="0">Cytokines</arg>
                    <arg n="1">the expression and activity of the multidrug resistance transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="EGRAM" no="137">
                    <text>The molecular lesion associated with s1031 is predicted to alter splicing, we looked at the sos-1 mRNA produced in this mutant.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="EGRAM" no="138">
                    <text>The molecular lesion associated with s1031 is predicted to be able to alter splicing, we looked at the sos-1 mRNA produced in this mutant.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="EGRAM" no="139">
                    <text>The results provide insight into a mechanism whereby altering expression of Bcl-3 leads to tumorigenic potential.</text>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="EGRAM" no="140">
                    <text>The results provide insight into a mechanism whereby the act of altering expression of Bcl-3 leads to tumorigenic potential.</text>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="EGRAM" no="141">
                    <text>The results provide insight into a mechanism whereby to alter expression of Bcl-3 may lead to tumorigenic potential.</text>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="EGRAM" no="142">
                    <text>The results provide insight into a mechanism which alters expression of Bcl-3 and leads to tumorigenic potential.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="EGRAM" no="143">
                    <text>The results provide insight into a mechanism which can alter expression of Bcl-3 and may lead to tumorigenic potential.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="EGRAM" no="144">
                    <text>This mutation is located within exon 2 and altered the codon (CTC) normally associated with Leu-93 in the transcortin polypeptide to a codon (CAC) for histidine in the variant genes.</text>
                    <arg n="0">This mutation</arg>
                    <arg n="1">the codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                    <arg n="3">the codon (CTC)</arg>
                </example>
                <example src="EGRAM" no="145">
                    <text>This mutation was located within exon 2 and altered the codon (CTC) normally associated with Leu-93 in the transcortin polypeptide to a codon (CAC) for histidine in the variant genes.</text>
                    <arg n="0">This mutation</arg>
                    <arg n="1">the codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                    <arg n="3">the codon (CTC)</arg>
                </example>
                <example src="EGRAM" no="146">
                    <text>This mutation, which alters the codon (CTC) normally associated with Leu-93 in the transcortin polypeptide to a codon (CAC) for histidine in the variant genes, is located within exon 2.</text>
                    <arg n="0">This mutation</arg>
                    <arg n="1">the codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                    <arg n="3">the codon (CTC)</arg>
                </example>
                <example src="EGRAM" no="147">
                    <text>Treating the cells with insulin-like growth factor-I cannot alter phosphorylation of PDK1 and four of the sites could be mutated without loss of activity.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="148">
                    <text>Treating the cells with insulin-like growth factor-I did not alter phosphorylation of PDK1 and four of the sites could be mutated without loss of activity.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="149">
                    <text>Treating the cells with insulin-like growth factor-I does not alter phosphorylation of PDK1 and four of the sites could be mutated without loss of activity.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="150">
                    <text>Treating the cells with insulin-like growth factor-I has not altered phosphorylation of PDK1 and four of the sites could be mutated without loss of activity.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="151">
                    <text>Treating the cells with insulin-like growth factor-I is not able to alter phosphorylation of PDK1 and four of the sites could be mutated without loss of activity.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="152">
                    <text>Treating the cells with insulin-like growth factor-I may not alter phosphorylation of PDK1 and four of the sites could be mutated without loss of activity.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="153">
                    <text>Treating the cells with insulin-like growth factor-I will not alter phosphorylation of PDK1 and four of the sites could be mutated without loss of activity.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EMBO" no="1">
                    <text>As the molecular lesion associated with s1031 is predicted to alter splicing, we looked at the sos-1 mRNA produced in this mutant.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="EMBO" no="2">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity, probably due to the change in DNA conformation, which subtly alters the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="EMBO" no="3">
                    <text>Phosphorylation of PDK1 was not altered by treating the cells with insulin-like growth factor-I and four of the sites could be mutated without loss of activity.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EMBO" no="4">
                    <text>Since s1031 is a null allele, we tested whether this mutation alters vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="EMBO" no="5">
                    <text>Since these two bends are in opposing directions, they do not alter the overall direction of the DNA(Figure 3C).</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="GREC" no="1">
                    <text>Moreover, Dam methylation inhibits binding of Lrp/PapI near the GATC1028 site and alters binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="GREC" no="2">
                    <text>Moreover, a fruR null mutation altered the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="GREC" no="3">
                    <text>Mutations which prevent repressor binding to either site or alter the phasing of the binding sites result in simultaneous derepression of both genes.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="GREC" no="4">
                    <text>The results provide insight into a mechanism whereby altered expression of Bcl-3 leads to tumorigenic potential.</text>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="MEDLINE" no="1">
                    <text>Cytokines alter the expression and activity of the multidrug resistance transporters in human hepatoma cell lines; analysis using RT-PCR and cDNA microarrays.</text>
                    <arg n="0">Cytokines</arg>
                    <arg n="1">the expression and activity of the multidrug resistance transporters</arg>
                    <arg n="4">human hepatoma cell lines</arg>
                </example>
                <example src="MEDLINE" no="2">
                    <text>Four other mutations alter either the conserved gt or ag dinucleotide splice sites in the IVD gene.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                    <arg n="4">the IVD gene</arg>
                </example>
                <example src="MEDLINE" no="3">
                    <text>In protein-coding transcripts, 79% of splice variations altered the protein product. Whole-transcriptome analyses resulted in the identification of 2,431 sense-antisense pairs.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="MEDLINE" no="4">
                    <text>Mutations that alter splice sites led to the synthesis of several types of mRNAs, a fraction of which represented the normally spliced product.</text>
                    <arg n="0">mutations</arg>
                    <arg n="1">splice sites</arg>
                </example>
                <example src="MEDLINE" no="5">
                    <text>This mutation is located within exon 2 and alters the codon (CTC) normally associated with Leu-93 in the transcortin polypeptide to a codon (CAC) for histidine in the variant genes.</text>
                    <arg n="0">This mutation</arg>
                    <arg n="1">the codon</arg>
                    <arg n="2">to a codon (CAC)</arg>
                    <arg n="3">the codon (CTC)</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because specific protein DNA interactions observed are able to be altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because specific protein DNA interactions observed can be altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because specific protein DNA interactions observed could be altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because specific protein DNA interactions observed is altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because specific protein DNA interactions observed may be altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because specific protein DNA interactions observed was altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the overall direction of the DNA are able to be altered by these two bends.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the overall direction of the DNA can be altered by these two bends.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the overall direction of the DNA could be altered by these two bends.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the overall direction of the DNA is altered by these two bends.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the overall direction of the DNA may be altered by these two bends.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the overall direction of the DNA was altered by these two bends.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the rates of utilization of at least 36 carbon sources are able to be altered by a fruR null mutation.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the rates of utilization of at least 36 carbon sources can be altered by a fruR null mutation.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the rates of utilization of at least 36 carbon sources could be altered by a fruR null mutation.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the rates of utilization of at least 36 carbon sources is altered by a fruR null mutation.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the rates of utilization of at least 36 carbon sources may be altered by a fruR null mutation.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the rates of utilization of at least 36 carbon sources was altered by a fruR null mutation.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because vulval induction are able to be altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because vulval induction can be altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because vulval induction could be altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because vulval induction is altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because vulval induction may be altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because vulval induction was altered by this mutation.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because a fruR null mutation can subtly alter the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because a fruR null mutation is able to subtly alter the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because a fruR null mutation may be able to subtly alter the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because a fruR null mutation may subtly alter the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because a fruR null mutation subtly altered the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because a fruR null mutation subtly alters the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because the change in DNA conformation can subtly alter specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because the change in DNA conformation is able to subtly alter specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because the change in DNA conformation may be able to subtly alter specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because the change in DNA conformation may subtly alter specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because the change in DNA conformation subtly altered specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because the change in DNA conformation subtly alters specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because these two bends can subtly alter the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because these two bends is able to subtly alter the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because these two bends may be able to subtly alter the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because these two bends may subtly alter the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because these two bends subtly altered the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because these two bends subtly alters the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because this mutation can subtly alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because this mutation is able to subtly alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because this mutation may be able to subtly alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because this mutation may subtly alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because this mutation subtly altered vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because this mutation subtly alters vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to a fruR null mutation, which can subtly alter the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to a fruR null mutation, which is able to subtly alter the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to a fruR null mutation, which may be able to subtly alter the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to a fruR null mutation, which may subtly alter the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to a fruR null mutation, which subtly altered the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to a fruR null mutation, which was able to subtly alter the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to the change in DNA conformation, which can subtly alter specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to the change in DNA conformation, which is able to subtly alter specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to the change in DNA conformation, which may be able to subtly alter specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to the change in DNA conformation, which may subtly alter specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to the change in DNA conformation, which subtly altered specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to the change in DNA conformation, which was able to subtly alter specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to these two bends, which can subtly alter the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to these two bends, which is able to subtly alter the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to these two bends, which may be able to subtly alter the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to these two bends, which may subtly alter the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to these two bends, which subtly altered the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to these two bends, which was able to subtly alter the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="67">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to this mutation, which can subtly alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="68">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to this mutation, which is able to subtly alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="69">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to this mutation, which may be able to subtly alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="70">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to this mutation, which may subtly alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="71">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to this mutation, which subtly altered vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="72">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to this mutation, which was able to subtly alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="73">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity, probably due to a fruR null mutation, which subtly alters the the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="74">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity, probably due to the change in DNA conformation, which subtly alters the the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="75">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity, probably due to these two bends, which subtly alters the the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="76">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity, probably due to this mutation, which subtly alters the vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="77">
                    <text>Moreover, the change in DNA conformation altered specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="78">
                    <text>Moreover, the change in DNA conformation altered the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="79">
                    <text>Moreover, the change in DNA conformation alters specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="80">
                    <text>Moreover, the change in DNA conformation alters the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="81">
                    <text>Moreover, the change in DNA conformation can alter specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="82">
                    <text>Moreover, the change in DNA conformation can alter the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="83">
                    <text>Moreover, the change in DNA conformation could alter specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="84">
                    <text>Moreover, the change in DNA conformation could alter the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="85">
                    <text>Moreover, the change in DNA conformation has altered specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="86">
                    <text>Moreover, the change in DNA conformation has altered the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="87">
                    <text>Moreover, the change in DNA conformation is able to alter specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="88">
                    <text>Moreover, the change in DNA conformation is able to alter the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="89">
                    <text>Moreover, the change in DNA conformation may alter specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="90">
                    <text>Moreover, the change in DNA conformation may alter the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="91">
                    <text>Moreover, the change in DNA conformation may be able to alter specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="92">
                    <text>Moreover, the change in DNA conformation may be able to alter the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="93">
                    <text>Moreover, the change in DNA conformation will alter specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="94">
                    <text>Moreover, the change in DNA conformation will alter the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="95">
                    <text>Moreover, the change in DNA conformation will be able to alter specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="96">
                    <text>Moreover, the change in DNA conformation will be able to alter the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="97">
                    <text>Moreover, these two bends altered the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="98">
                    <text>Moreover, these two bends alters the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="99">
                    <text>Moreover, these two bends can alter the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="100">
                    <text>Moreover, these two bends could alter the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="101">
                    <text>Moreover, these two bends has altered the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="102">
                    <text>Moreover, these two bends is able to alter the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="103">
                    <text>Moreover, these two bends may alter the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="104">
                    <text>Moreover, these two bends may be able to alter the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="105">
                    <text>Moreover, these two bends will alter the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="106">
                    <text>Moreover, these two bends will be able to alter the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="107">
                    <text>Moreover, this mutation altered vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="108">
                    <text>Moreover, this mutation alters vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="109">
                    <text>Moreover, this mutation can alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="110">
                    <text>Moreover, this mutation could alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="111">
                    <text>Moreover, this mutation has altered vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="112">
                    <text>Moreover, this mutation is able to alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="113">
                    <text>Moreover, this mutation may alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="114">
                    <text>Moreover, this mutation may be able to alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="115">
                    <text>Moreover, this mutation will alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="116">
                    <text>Moreover, this mutation will be able to alter vulval induction.</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="117">
                    <text>Since a fruR null mutation are in opposing directions, the rates of utilization of at least 36 carbon sources cannot be altered by them(Figure 3C).</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="118">
                    <text>Since a fruR null mutation are in opposing directions, the rates of utilization of at least 36 carbon sources is not able to be altered by them(Figure 3C).</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="119">
                    <text>Since a fruR null mutation are in opposing directions, the rates of utilization of at least 36 carbon sources is not altered by them(Figure 3C).</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="120">
                    <text>Since a fruR null mutation are in opposing directions, the rates of utilization of at least 36 carbon sources may not be altered by them(Figure 3C).</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="121">
                    <text>Since a fruR null mutation are in opposing directions, the rates of utilization of at least 36 carbon sources will not be altered by them(Figure 3C).</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="122">
                    <text>Since a fruR null mutation are in opposing directions, they are not able to alter the rates of utilization of at least 36 carbon sources(Figure 3C).</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="123">
                    <text>Since a fruR null mutation are in opposing directions, they cannot alter the rates of utilization of at least 36 carbon sources(Figure 3C).</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="124">
                    <text>Since a fruR null mutation are in opposing directions, they do not alter the rates of utilization of at least 36 carbon sources(Figure 3C).</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="125">
                    <text>Since a fruR null mutation are in opposing directions, they may not alter the rates of utilization of at least 36 carbon sources(Figure 3C).</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="126">
                    <text>Since a fruR null mutation are in opposing directions, they will not alter the rates of utilization of at least 36 carbon sources(Figure 3C).</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="127">
                    <text>Since a fruR null mutation were in opposing directions, the rates of utilization of at least 36 carbon sources could not be altered by them(Figure 3C).</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="128">
                    <text>Since a fruR null mutation were in opposing directions, the rates of utilization of at least 36 carbon sources was not able to be altered by them(Figure 3C).</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="129">
                    <text>Since a fruR null mutation were in opposing directions, the rates of utilization of at least 36 carbon sources was not altered by them(Figure 3C).</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="130">
                    <text>Since a fruR null mutation were in opposing directions, they could not alter the rates of utilization of at least 36 carbon sources(Figure 3C).</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="131">
                    <text>Since a fruR null mutation were in opposing directions, they did not alter the rates of utilization of at least 36 carbon sources(Figure 3C).</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="132">
                    <text>Since a fruR null mutation were in opposing directions, they were not able to alter the rates of utilization of at least 36 carbon sources(Figure 3C).</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="133">
                    <text>Since s1031 is a null allele, we are testing whether a fruR null mutation can alter the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="134">
                    <text>Since s1031 is a null allele, we are testing whether a fruR null mutation is able to alter the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="135">
                    <text>Since s1031 is a null allele, we are testing whether a fruR null mutation is going to alter the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="136">
                    <text>Since s1031 is a null allele, we are testing whether a fruR null mutation may alter the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="137">
                    <text>Since s1031 is a null allele, we are testing whether a fruR null mutation will alter the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="138">
                    <text>Since s1031 is a null allele, we are testing whether specific protein DNA interactions observed can be altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="139">
                    <text>Since s1031 is a null allele, we are testing whether specific protein DNA interactions observed is able to be altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="140">
                    <text>Since s1031 is a null allele, we are testing whether specific protein DNA interactions observed is altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="141">
                    <text>Since s1031 is a null allele, we are testing whether specific protein DNA interactions observed may be altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="142">
                    <text>Since s1031 is a null allele, we are testing whether the change in DNA conformation can alter specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="143">
                    <text>Since s1031 is a null allele, we are testing whether the change in DNA conformation can alter the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="144">
                    <text>Since s1031 is a null allele, we are testing whether the change in DNA conformation is able to alter specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="145">
                    <text>Since s1031 is a null allele, we are testing whether the change in DNA conformation is able to alter the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="146">
                    <text>Since s1031 is a null allele, we are testing whether the change in DNA conformation is going to alter specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="147">
                    <text>Since s1031 is a null allele, we are testing whether the change in DNA conformation is going to alter the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="148">
                    <text>Since s1031 is a null allele, we are testing whether the change in DNA conformation may alter specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="149">
                    <text>Since s1031 is a null allele, we are testing whether the change in DNA conformation may alter the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="150">
                    <text>Since s1031 is a null allele, we are testing whether the change in DNA conformation will alter specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="151">
                    <text>Since s1031 is a null allele, we are testing whether the change in DNA conformation will alter the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="152">
                    <text>Since s1031 is a null allele, we are testing whether the overall direction of the DNA can be altered by these two bends.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="153">
                    <text>Since s1031 is a null allele, we are testing whether the overall direction of the DNA is able to be altered by these two bends.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="154">
                    <text>Since s1031 is a null allele, we are testing whether the overall direction of the DNA is altered by these two bends.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="155">
                    <text>Since s1031 is a null allele, we are testing whether the overall direction of the DNA may be altered by these two bends.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="156">
                    <text>Since s1031 is a null allele, we are testing whether the rates of utilization of at least 36 carbon sources can be altered by a fruR null mutation.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="157">
                    <text>Since s1031 is a null allele, we are testing whether the rates of utilization of at least 36 carbon sources is able to be altered by a fruR null mutation.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="158">
                    <text>Since s1031 is a null allele, we are testing whether the rates of utilization of at least 36 carbon sources is altered by a fruR null mutation.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="159">
                    <text>Since s1031 is a null allele, we are testing whether the rates of utilization of at least 36 carbon sources may be altered by a fruR null mutation.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="160">
                    <text>Since s1031 is a null allele, we are testing whether the specific protein DNA interactions observed can be altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="161">
                    <text>Since s1031 is a null allele, we are testing whether the specific protein DNA interactions observed is able to be altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="162">
                    <text>Since s1031 is a null allele, we are testing whether the specific protein DNA interactions observed is altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="163">
                    <text>Since s1031 is a null allele, we are testing whether the specific protein DNA interactions observed may be altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="164">
                    <text>Since s1031 is a null allele, we are testing whether these two bends can alter the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="165">
                    <text>Since s1031 is a null allele, we are testing whether these two bends is able to alter the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="166">
                    <text>Since s1031 is a null allele, we are testing whether these two bends is going to alter the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="167">
                    <text>Since s1031 is a null allele, we are testing whether these two bends may alter the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="168">
                    <text>Since s1031 is a null allele, we are testing whether these two bends will alter the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="169">
                    <text>Since s1031 is a null allele, we tested whether a fruR null mutation altered the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="170">
                    <text>Since s1031 is a null allele, we tested whether a fruR null mutation alters the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="171">
                    <text>Since s1031 is a null allele, we tested whether a fruR null mutation could alter the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="172">
                    <text>Since s1031 is a null allele, we tested whether a fruR null mutation has altered the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="173">
                    <text>Since s1031 is a null allele, we tested whether a fruR null mutation might alter the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="174">
                    <text>Since s1031 is a null allele, we tested whether a fruR null mutation was able to alter the rates of utilization of at least 36 carbon sources.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="175">
                    <text>Since s1031 is a null allele, we tested whether specific protein DNA interactions observed could be altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="176">
                    <text>Since s1031 is a null allele, we tested whether specific protein DNA interactions observed might be altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="177">
                    <text>Since s1031 is a null allele, we tested whether specific protein DNA interactions observed was able to be altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="178">
                    <text>Since s1031 is a null allele, we tested whether specific protein DNA interactions observed was altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="179">
                    <text>Since s1031 is a null allele, we tested whether the change in DNA conformation altered specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="180">
                    <text>Since s1031 is a null allele, we tested whether the change in DNA conformation altered the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="181">
                    <text>Since s1031 is a null allele, we tested whether the change in DNA conformation alters specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="182">
                    <text>Since s1031 is a null allele, we tested whether the change in DNA conformation alters the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="183">
                    <text>Since s1031 is a null allele, we tested whether the change in DNA conformation could alter specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="184">
                    <text>Since s1031 is a null allele, we tested whether the change in DNA conformation could alter the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="185">
                    <text>Since s1031 is a null allele, we tested whether the change in DNA conformation has altered specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="186">
                    <text>Since s1031 is a null allele, we tested whether the change in DNA conformation has altered the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="187">
                    <text>Since s1031 is a null allele, we tested whether the change in DNA conformation might alter specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="188">
                    <text>Since s1031 is a null allele, we tested whether the change in DNA conformation might alter the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="189">
                    <text>Since s1031 is a null allele, we tested whether the change in DNA conformation was able to alter specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="190">
                    <text>Since s1031 is a null allele, we tested whether the change in DNA conformation was able to alter the specific protein DNA interactions observed.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="191">
                    <text>Since s1031 is a null allele, we tested whether the overall direction of the DNA could be altered by these two bends.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="192">
                    <text>Since s1031 is a null allele, we tested whether the overall direction of the DNA might be altered by these two bends.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="193">
                    <text>Since s1031 is a null allele, we tested whether the overall direction of the DNA was able to be altered by these two bends.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="194">
                    <text>Since s1031 is a null allele, we tested whether the overall direction of the DNA was altered by these two bends.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="195">
                    <text>Since s1031 is a null allele, we tested whether the rates of utilization of at least 36 carbon sources could be altered by a fruR null mutation.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="196">
                    <text>Since s1031 is a null allele, we tested whether the rates of utilization of at least 36 carbon sources might be altered by a fruR null mutation.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="197">
                    <text>Since s1031 is a null allele, we tested whether the rates of utilization of at least 36 carbon sources was able to be altered by a fruR null mutation.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="198">
                    <text>Since s1031 is a null allele, we tested whether the rates of utilization of at least 36 carbon sources was altered by a fruR null mutation.</text>
                    <arg n="0">a fruR null mutation</arg>
                    <arg n="1">the rates of utilization of at least 36 carbon sources</arg>
                </example>
                <example src="PERMUTATE" no="199">
                    <text>Since s1031 is a null allele, we tested whether the specific protein DNA interactions observed could be altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="200">
                    <text>Since s1031 is a null allele, we tested whether the specific protein DNA interactions observed might be altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="201">
                    <text>Since s1031 is a null allele, we tested whether the specific protein DNA interactions observed was able to be altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="202">
                    <text>Since s1031 is a null allele, we tested whether the specific protein DNA interactions observed was altered by the change in DNA conformation.</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="203">
                    <text>Since s1031 is a null allele, we tested whether these two bends altered the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="204">
                    <text>Since s1031 is a null allele, we tested whether these two bends alters the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="205">
                    <text>Since s1031 is a null allele, we tested whether these two bends could alter the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="206">
                    <text>Since s1031 is a null allele, we tested whether these two bends has altered the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="207">
                    <text>Since s1031 is a null allele, we tested whether these two bends might alter the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="208">
                    <text>Since s1031 is a null allele, we tested whether these two bends was able to alter the overall direction of the DNA.</text>
                    <arg n="0">these two bends</arg>
                    <arg n="1">the overall direction of the DNA</arg>
                </example>
                <example src="PERMUTATE" no="209">
                    <text>Since the change in DNA conformation are in opposing directions, specific protein DNA interactions observed cannot be altered by them(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="210">
                    <text>Since the change in DNA conformation are in opposing directions, specific protein DNA interactions observed is not able to be altered by them(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="211">
                    <text>Since the change in DNA conformation are in opposing directions, specific protein DNA interactions observed is not altered by them(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="212">
                    <text>Since the change in DNA conformation are in opposing directions, specific protein DNA interactions observed may not be altered by them(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="213">
                    <text>Since the change in DNA conformation are in opposing directions, specific protein DNA interactions observed will not be altered by them(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="214">
                    <text>Since the change in DNA conformation are in opposing directions, the specific protein DNA interactions observed cannot be altered by them(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="215">
                    <text>Since the change in DNA conformation are in opposing directions, the specific protein DNA interactions observed is not able to be altered by them(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="216">
                    <text>Since the change in DNA conformation are in opposing directions, the specific protein DNA interactions observed is not altered by them(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="217">
                    <text>Since the change in DNA conformation are in opposing directions, the specific protein DNA interactions observed may not be altered by them(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="218">
                    <text>Since the change in DNA conformation are in opposing directions, the specific protein DNA interactions observed will not be altered by them(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="219">
                    <text>Since the change in DNA conformation are in opposing directions, they are not able to alter specific protein DNA interactions observed(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="220">
                    <text>Since the change in DNA conformation are in opposing directions, they are not able to alter the specific protein DNA interactions observed(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="221">
                    <text>Since the change in DNA conformation are in opposing directions, they cannot alter specific protein DNA interactions observed(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="222">
                    <text>Since the change in DNA conformation are in opposing directions, they cannot alter the specific protein DNA interactions observed(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="223">
                    <text>Since the change in DNA conformation are in opposing directions, they do not alter specific protein DNA interactions observed(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="224">
                    <text>Since the change in DNA conformation are in opposing directions, they do not alter the specific protein DNA interactions observed(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="225">
                    <text>Since the change in DNA conformation are in opposing directions, they may not alter specific protein DNA interactions observed(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="226">
                    <text>Since the change in DNA conformation are in opposing directions, they may not alter the specific protein DNA interactions observed(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="227">
                    <text>Since the change in DNA conformation are in opposing directions, they will not alter specific protein DNA interactions observed(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="228">
                    <text>Since the change in DNA conformation are in opposing directions, they will not alter the specific protein DNA interactions observed(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="229">
                    <text>Since the change in DNA conformation were in opposing directions, specific protein DNA interactions observed could not be altered by them(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="230">
                    <text>Since the change in DNA conformation were in opposing directions, specific protein DNA interactions observed was not able to be altered by them(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="231">
                    <text>Since the change in DNA conformation were in opposing directions, specific protein DNA interactions observed was not altered by them(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="232">
                    <text>Since the change in DNA conformation were in opposing directions, the specific protein DNA interactions observed could not be altered by them(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="233">
                    <text>Since the change in DNA conformation were in opposing directions, the specific protein DNA interactions observed was not able to be altered by them(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="234">
                    <text>Since the change in DNA conformation were in opposing directions, the specific protein DNA interactions observed was not altered by them(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="235">
                    <text>Since the change in DNA conformation were in opposing directions, they could not alter specific protein DNA interactions observed(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="236">
                    <text>Since the change in DNA conformation were in opposing directions, they could not alter the specific protein DNA interactions observed(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="237">
                    <text>Since the change in DNA conformation were in opposing directions, they did not alter specific protein DNA interactions observed(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="238">
                    <text>Since the change in DNA conformation were in opposing directions, they did not alter the specific protein DNA interactions observed(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="239">
                    <text>Since the change in DNA conformation were in opposing directions, they were not able to alter specific protein DNA interactions observed(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="240">
                    <text>Since the change in DNA conformation were in opposing directions, they were not able to alter the specific protein DNA interactions observed(Figure 3C).</text>
                    <arg n="0">the change in DNA conformation</arg>
                    <arg n="1">the specific protein DNA interactions observed</arg>
                </example>
                <example src="PERMUTATE" no="241">
                    <text>Since this mutation are in opposing directions, they are not able to alter vulval induction(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="242">
                    <text>Since this mutation are in opposing directions, they cannot alter vulval induction(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="243">
                    <text>Since this mutation are in opposing directions, they do not alter vulval induction(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="244">
                    <text>Since this mutation are in opposing directions, they may not alter vulval induction(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="245">
                    <text>Since this mutation are in opposing directions, they will not alter vulval induction(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="246">
                    <text>Since this mutation are in opposing directions, vulval induction cannot be altered by them(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="247">
                    <text>Since this mutation are in opposing directions, vulval induction is not able to be altered by them(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="248">
                    <text>Since this mutation are in opposing directions, vulval induction is not altered by them(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="249">
                    <text>Since this mutation are in opposing directions, vulval induction may not be altered by them(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="250">
                    <text>Since this mutation are in opposing directions, vulval induction will not be altered by them(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="251">
                    <text>Since this mutation were in opposing directions, they could not alter vulval induction(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="252">
                    <text>Since this mutation were in opposing directions, they did not alter vulval induction(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="253">
                    <text>Since this mutation were in opposing directions, they were not able to alter vulval induction(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="254">
                    <text>Since this mutation were in opposing directions, vulval induction could not be altered by them(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="255">
                    <text>Since this mutation were in opposing directions, vulval induction was not able to be altered by them(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="PERMUTATE" no="256">
                    <text>Since this mutation were in opposing directions, vulval induction was not altered by them(Figure 3C).</text>
                    <arg n="0">this mutation</arg>
                    <arg n="1">vulval induction</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because Phosphorylation of PDK1 are able to be altered by treating the cells with insulin-like growth factor-I.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because Phosphorylation of PDK1 can be altered by treating the cells with insulin-like growth factor-I.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because Phosphorylation of PDK1 could be altered by treating the cells with insulin-like growth factor-I.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because Phosphorylation of PDK1 is altered by treating the cells with insulin-like growth factor-I.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because Phosphorylation of PDK1 may be altered by treating the cells with insulin-like growth factor-I.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because Phosphorylation of PDK1 was altered by treating the cells with insulin-like growth factor-I.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because binding of Lrp at the GATC1130 site are able to be altered by Dam methylation.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because binding of Lrp at the GATC1130 site can be altered by Dam methylation.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because binding of Lrp at the GATC1130 site could be altered by Dam methylation.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because binding of Lrp at the GATC1130 site is altered by Dam methylation.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because binding of Lrp at the GATC1130 site may be altered by Dam methylation.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because binding of Lrp at the GATC1130 site was altered by Dam methylation.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because either the conserved gt or ag dinucleotide splice sites are able to be altered by Four other mutations.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because either the conserved gt or ag dinucleotide splice sites can be altered by Four other mutations.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because either the conserved gt or ag dinucleotide splice sites could be altered by Four other mutations.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because either the conserved gt or ag dinucleotide splice sites is altered by Four other mutations.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because either the conserved gt or ag dinucleotide splice sites may be altered by Four other mutations.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because either the conserved gt or ag dinucleotide splice sites was altered by Four other mutations.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because expression of Bcl-3 are able to be altered by a mechanism.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because expression of Bcl-3 can be altered by a mechanism.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because expression of Bcl-3 could be altered by a mechanism.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because expression of Bcl-3 is altered by a mechanism.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because expression of Bcl-3 may be altered by a mechanism.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because expression of Bcl-3 was altered by a mechanism.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because splicing are able to be altered by the molecular lesion associated with s1031.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because splicing can be altered by the molecular lesion associated with s1031.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because splicing could be altered by the molecular lesion associated with s1031.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because splicing is altered by the molecular lesion associated with s1031.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because splicing may be altered by the molecular lesion associated with s1031.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because splicing was altered by the molecular lesion associated with s1031.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the phasing of the binding sites are able to be altered by Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the phasing of the binding sites can be altered by Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the phasing of the binding sites could be altered by Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the phasing of the binding sites is altered by Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the phasing of the binding sites may be altered by Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the phasing of the binding sites was altered by Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the protein product are able to be altered by splice variations.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the protein product can be altered by splice variations.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the protein product could be altered by splice variations.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the protein product is altered by splice variations.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the protein product may be altered by splice variations.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity because the protein product was altered by splice variations.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because Dam methylation can subtly alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because Dam methylation is able to subtly alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because Dam methylation may be able to subtly alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because Dam methylation may subtly alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because Dam methylation subtly altered binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because Dam methylation subtly alters binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because Four other mutations can subtly alter either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because Four other mutations is able to subtly alter either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because Four other mutations may be able to subtly alter either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because Four other mutations may subtly alter either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="53">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because Four other mutations subtly altered either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="54">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because Four other mutations subtly alters either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="55">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because Mutations can subtly alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="56">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because Mutations is able to subtly alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="57">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because Mutations may be able to subtly alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="58">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because Mutations may subtly alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="59">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because Mutations subtly altered the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="60">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because Mutations subtly alters the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="61">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because a mechanism can subtly alter expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="62">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because a mechanism is able to subtly alter expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="63">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because a mechanism may be able to subtly alter expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="64">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because a mechanism may subtly alter expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="65">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because a mechanism subtly altered expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="66">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because a mechanism subtly alters expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="67">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because splice variations can subtly alter the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="68">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because splice variations is able to subtly alter the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="69">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because splice variations may be able to subtly alter the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="70">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because splice variations may subtly alter the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="71">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because splice variations subtly altered the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="72">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because splice variations subtly alters the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="73">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because the molecular lesion associated with s1031 can subtly alter splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="74">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because the molecular lesion associated with s1031 is able to subtly alter splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="75">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because the molecular lesion associated with s1031 may be able to subtly alter splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="76">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because the molecular lesion associated with s1031 may subtly alter splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="77">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because the molecular lesion associated with s1031 subtly altered splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="78">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because the molecular lesion associated with s1031 subtly alters splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="79">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because treating the cells with insulin-like growth factor-I can subtly alter Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="80">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because treating the cells with insulin-like growth factor-I is able to subtly alter Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="81">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because treating the cells with insulin-like growth factor-I may be able to subtly alter Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="82">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because treating the cells with insulin-like growth factor-I may subtly alter Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="83">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because treating the cells with insulin-like growth factor-I subtly altered Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="84">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably because treating the cells with insulin-like growth factor-I subtly alters Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="85">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to Dam methylation, which can subtly alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="86">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to Dam methylation, which is able to subtly alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="87">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to Dam methylation, which may be able to subtly alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="88">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to Dam methylation, which may subtly alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="89">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to Dam methylation, which subtly altered binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="90">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to Dam methylation, which was able to subtly alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="91">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to Four other mutations, which can subtly alter either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="92">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to Four other mutations, which is able to subtly alter either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="93">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to Four other mutations, which may be able to subtly alter either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="94">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to Four other mutations, which may subtly alter either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="95">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to Four other mutations, which subtly altered either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="96">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to Four other mutations, which was able to subtly alter either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="97">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to Mutations, which can subtly alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="98">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to Mutations, which is able to subtly alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="99">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to Mutations, which may be able to subtly alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="100">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to Mutations, which may subtly alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="101">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to Mutations, which subtly altered the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="102">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to Mutations, which was able to subtly alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="103">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to a mechanism, which can subtly alter expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="104">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to a mechanism, which is able to subtly alter expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="105">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to a mechanism, which may be able to subtly alter expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="106">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to a mechanism, which may subtly alter expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="107">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to a mechanism, which subtly altered expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="108">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to a mechanism, which was able to subtly alter expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="109">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to splice variations, which can subtly alter the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="110">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to splice variations, which is able to subtly alter the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="111">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to splice variations, which may be able to subtly alter the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="112">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to splice variations, which may subtly alter the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="113">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to splice variations, which subtly altered the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="114">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to splice variations, which was able to subtly alter the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="115">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to the molecular lesion associated with s1031, which can subtly alter splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="116">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to the molecular lesion associated with s1031, which is able to subtly alter splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="117">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to the molecular lesion associated with s1031, which may be able to subtly alter splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="118">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to the molecular lesion associated with s1031, which may subtly alter splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="119">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to the molecular lesion associated with s1031, which subtly altered splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="120">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to the molecular lesion associated with s1031, which was able to subtly alter splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="121">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to treating the cells with insulin-like growth factor-I, which can subtly alter Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="122">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to treating the cells with insulin-like growth factor-I, which is able to subtly alter Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="123">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to treating the cells with insulin-like growth factor-I, which may be able to subtly alter Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="124">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to treating the cells with insulin-like growth factor-I, which may subtly alter Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="125">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to treating the cells with insulin-like growth factor-I, which subtly altered Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="126">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity probably due to treating the cells with insulin-like growth factor-I, which was able to subtly alter Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="127">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity, probably due to Dam methylation, which subtly alters the binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="128">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity, probably due to Four other mutations, which subtly alters the either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="129">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity, probably due to Mutations, which subtly alters the the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="130">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity, probably due to a mechanism, which subtly alters the expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="131">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity, probably due to splice variations, which subtly alters the the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="132">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity, probably due to the molecular lesion associated with s1031, which subtly alters the splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="133">
                    <text>Hence, Glu13 indirectly affects DNA-binding specificity, probably due to treating the cells with insulin-like growth factor-I, which subtly alters the Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="134">
                    <text>Moreover, Dam methylation altered binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="135">
                    <text>Moreover, Dam methylation alters binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="136">
                    <text>Moreover, Dam methylation can alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="137">
                    <text>Moreover, Dam methylation could alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="138">
                    <text>Moreover, Dam methylation has altered binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="139">
                    <text>Moreover, Dam methylation is able to alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="140">
                    <text>Moreover, Dam methylation may alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="141">
                    <text>Moreover, Dam methylation may be able to alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="142">
                    <text>Moreover, Dam methylation will alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="143">
                    <text>Moreover, Dam methylation will be able to alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="144">
                    <text>Moreover, Four other mutations altered either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="145">
                    <text>Moreover, Four other mutations alters either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="146">
                    <text>Moreover, Four other mutations can alter either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="147">
                    <text>Moreover, Four other mutations could alter either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="148">
                    <text>Moreover, Four other mutations has altered either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="149">
                    <text>Moreover, Four other mutations is able to alter either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="150">
                    <text>Moreover, Four other mutations may alter either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="151">
                    <text>Moreover, Four other mutations may be able to alter either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="152">
                    <text>Moreover, Four other mutations will alter either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="153">
                    <text>Moreover, Four other mutations will be able to alter either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="154">
                    <text>Moreover, Mutations altered the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="155">
                    <text>Moreover, Mutations alters the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="156">
                    <text>Moreover, Mutations can alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="157">
                    <text>Moreover, Mutations could alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="158">
                    <text>Moreover, Mutations has altered the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="159">
                    <text>Moreover, Mutations is able to alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="160">
                    <text>Moreover, Mutations may alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="161">
                    <text>Moreover, Mutations may be able to alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="162">
                    <text>Moreover, Mutations will alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="163">
                    <text>Moreover, Mutations will be able to alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="164">
                    <text>Moreover, a mechanism altered expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="165">
                    <text>Moreover, a mechanism alters expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="166">
                    <text>Moreover, a mechanism can alter expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="167">
                    <text>Moreover, a mechanism could alter expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="168">
                    <text>Moreover, a mechanism has altered expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="169">
                    <text>Moreover, a mechanism is able to alter expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="170">
                    <text>Moreover, a mechanism may alter expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="171">
                    <text>Moreover, a mechanism may be able to alter expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="172">
                    <text>Moreover, a mechanism will alter expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="173">
                    <text>Moreover, a mechanism will be able to alter expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="174">
                    <text>Moreover, splice variations altered the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="175">
                    <text>Moreover, splice variations alters the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="176">
                    <text>Moreover, splice variations can alter the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="177">
                    <text>Moreover, splice variations could alter the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="178">
                    <text>Moreover, splice variations has altered the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="179">
                    <text>Moreover, splice variations is able to alter the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="180">
                    <text>Moreover, splice variations may alter the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="181">
                    <text>Moreover, splice variations may be able to alter the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="182">
                    <text>Moreover, splice variations will alter the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="183">
                    <text>Moreover, splice variations will be able to alter the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="184">
                    <text>Moreover, the molecular lesion associated with s1031 altered splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="185">
                    <text>Moreover, the molecular lesion associated with s1031 alters splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="186">
                    <text>Moreover, the molecular lesion associated with s1031 can alter splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="187">
                    <text>Moreover, the molecular lesion associated with s1031 could alter splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="188">
                    <text>Moreover, the molecular lesion associated with s1031 has altered splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="189">
                    <text>Moreover, the molecular lesion associated with s1031 is able to alter splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="190">
                    <text>Moreover, the molecular lesion associated with s1031 may alter splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="191">
                    <text>Moreover, the molecular lesion associated with s1031 may be able to alter splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="192">
                    <text>Moreover, the molecular lesion associated with s1031 will alter splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="193">
                    <text>Moreover, the molecular lesion associated with s1031 will be able to alter splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="194">
                    <text>Moreover, treating the cells with insulin-like growth factor-I altered Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="195">
                    <text>Moreover, treating the cells with insulin-like growth factor-I alters Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="196">
                    <text>Moreover, treating the cells with insulin-like growth factor-I can alter Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="197">
                    <text>Moreover, treating the cells with insulin-like growth factor-I could alter Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="198">
                    <text>Moreover, treating the cells with insulin-like growth factor-I has altered Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="199">
                    <text>Moreover, treating the cells with insulin-like growth factor-I is able to alter Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="200">
                    <text>Moreover, treating the cells with insulin-like growth factor-I may alter Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="201">
                    <text>Moreover, treating the cells with insulin-like growth factor-I may be able to alter Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="202">
                    <text>Moreover, treating the cells with insulin-like growth factor-I will alter Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="203">
                    <text>Moreover, treating the cells with insulin-like growth factor-I will be able to alter Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="204">
                    <text>Since Dam methylation are in opposing directions, binding of Lrp at the GATC1130 site cannot be altered by them(Figure 3C).</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="205">
                    <text>Since Dam methylation are in opposing directions, binding of Lrp at the GATC1130 site is not able to be altered by them(Figure 3C).</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="206">
                    <text>Since Dam methylation are in opposing directions, binding of Lrp at the GATC1130 site is not altered by them(Figure 3C).</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="207">
                    <text>Since Dam methylation are in opposing directions, binding of Lrp at the GATC1130 site may not be altered by them(Figure 3C).</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="208">
                    <text>Since Dam methylation are in opposing directions, binding of Lrp at the GATC1130 site will not be altered by them(Figure 3C).</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="209">
                    <text>Since Dam methylation are in opposing directions, they are not able to alter binding of Lrp at the GATC1130 site(Figure 3C).</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="210">
                    <text>Since Dam methylation are in opposing directions, they cannot alter binding of Lrp at the GATC1130 site(Figure 3C).</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="211">
                    <text>Since Dam methylation are in opposing directions, they do not alter binding of Lrp at the GATC1130 site(Figure 3C).</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="212">
                    <text>Since Dam methylation are in opposing directions, they may not alter binding of Lrp at the GATC1130 site(Figure 3C).</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="213">
                    <text>Since Dam methylation are in opposing directions, they will not alter binding of Lrp at the GATC1130 site(Figure 3C).</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="214">
                    <text>Since Dam methylation were in opposing directions, binding of Lrp at the GATC1130 site could not be altered by them(Figure 3C).</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="215">
                    <text>Since Dam methylation were in opposing directions, binding of Lrp at the GATC1130 site was not able to be altered by them(Figure 3C).</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="216">
                    <text>Since Dam methylation were in opposing directions, binding of Lrp at the GATC1130 site was not altered by them(Figure 3C).</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="217">
                    <text>Since Dam methylation were in opposing directions, they could not alter binding of Lrp at the GATC1130 site(Figure 3C).</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="218">
                    <text>Since Dam methylation were in opposing directions, they did not alter binding of Lrp at the GATC1130 site(Figure 3C).</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="219">
                    <text>Since Dam methylation were in opposing directions, they were not able to alter binding of Lrp at the GATC1130 site(Figure 3C).</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="220">
                    <text>Since Four other mutations are in opposing directions, either the conserved gt or ag dinucleotide splice sites cannot be altered by them(Figure 3C).</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="221">
                    <text>Since Four other mutations are in opposing directions, either the conserved gt or ag dinucleotide splice sites is not able to be altered by them(Figure 3C).</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="222">
                    <text>Since Four other mutations are in opposing directions, either the conserved gt or ag dinucleotide splice sites is not altered by them(Figure 3C).</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="223">
                    <text>Since Four other mutations are in opposing directions, either the conserved gt or ag dinucleotide splice sites may not be altered by them(Figure 3C).</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="224">
                    <text>Since Four other mutations are in opposing directions, either the conserved gt or ag dinucleotide splice sites will not be altered by them(Figure 3C).</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="225">
                    <text>Since Four other mutations are in opposing directions, they are not able to alter either the conserved gt or ag dinucleotide splice sites(Figure 3C).</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="226">
                    <text>Since Four other mutations are in opposing directions, they cannot alter either the conserved gt or ag dinucleotide splice sites(Figure 3C).</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="227">
                    <text>Since Four other mutations are in opposing directions, they do not alter either the conserved gt or ag dinucleotide splice sites(Figure 3C).</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="228">
                    <text>Since Four other mutations are in opposing directions, they may not alter either the conserved gt or ag dinucleotide splice sites(Figure 3C).</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="229">
                    <text>Since Four other mutations are in opposing directions, they will not alter either the conserved gt or ag dinucleotide splice sites(Figure 3C).</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="230">
                    <text>Since Four other mutations were in opposing directions, either the conserved gt or ag dinucleotide splice sites could not be altered by them(Figure 3C).</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="231">
                    <text>Since Four other mutations were in opposing directions, either the conserved gt or ag dinucleotide splice sites was not able to be altered by them(Figure 3C).</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="232">
                    <text>Since Four other mutations were in opposing directions, either the conserved gt or ag dinucleotide splice sites was not altered by them(Figure 3C).</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="233">
                    <text>Since Four other mutations were in opposing directions, they could not alter either the conserved gt or ag dinucleotide splice sites(Figure 3C).</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="234">
                    <text>Since Four other mutations were in opposing directions, they did not alter either the conserved gt or ag dinucleotide splice sites(Figure 3C).</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="235">
                    <text>Since Four other mutations were in opposing directions, they were not able to alter either the conserved gt or ag dinucleotide splice sites(Figure 3C).</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="236">
                    <text>Since Mutations are in opposing directions, the phasing of the binding sites cannot be altered by them(Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="237">
                    <text>Since Mutations are in opposing directions, the phasing of the binding sites is not able to be altered by them(Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="238">
                    <text>Since Mutations are in opposing directions, the phasing of the binding sites is not altered by them(Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="239">
                    <text>Since Mutations are in opposing directions, the phasing of the binding sites may not be altered by them(Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="240">
                    <text>Since Mutations are in opposing directions, the phasing of the binding sites will not be altered by them(Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="241">
                    <text>Since Mutations are in opposing directions, they are not able to alter the phasing of the binding sites(Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="242">
                    <text>Since Mutations are in opposing directions, they cannot alter the phasing of the binding sites(Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="243">
                    <text>Since Mutations are in opposing directions, they do not alter the phasing of the binding sites(Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="244">
                    <text>Since Mutations are in opposing directions, they may not alter the phasing of the binding sites(Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="245">
                    <text>Since Mutations are in opposing directions, they will not alter the phasing of the binding sites(Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="246">
                    <text>Since Mutations were in opposing directions, the phasing of the binding sites could not be altered by them(Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="247">
                    <text>Since Mutations were in opposing directions, the phasing of the binding sites was not able to be altered by them(Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="248">
                    <text>Since Mutations were in opposing directions, the phasing of the binding sites was not altered by them(Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="249">
                    <text>Since Mutations were in opposing directions, they could not alter the phasing of the binding sites(Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="250">
                    <text>Since Mutations were in opposing directions, they did not alter the phasing of the binding sites(Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="251">
                    <text>Since Mutations were in opposing directions, they were not able to alter the phasing of the binding sites(Figure 3C).</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="252">
                    <text>Since a mechanism are in opposing directions, expression of Bcl-3 cannot be altered by them(Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="253">
                    <text>Since a mechanism are in opposing directions, expression of Bcl-3 is not able to be altered by them(Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="254">
                    <text>Since a mechanism are in opposing directions, expression of Bcl-3 is not altered by them(Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="255">
                    <text>Since a mechanism are in opposing directions, expression of Bcl-3 may not be altered by them(Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="256">
                    <text>Since a mechanism are in opposing directions, expression of Bcl-3 will not be altered by them(Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="257">
                    <text>Since a mechanism are in opposing directions, they are not able to alter expression of Bcl-3(Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="258">
                    <text>Since a mechanism are in opposing directions, they cannot alter expression of Bcl-3(Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="259">
                    <text>Since a mechanism are in opposing directions, they do not alter expression of Bcl-3(Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="260">
                    <text>Since a mechanism are in opposing directions, they may not alter expression of Bcl-3(Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="261">
                    <text>Since a mechanism are in opposing directions, they will not alter expression of Bcl-3(Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="262">
                    <text>Since a mechanism were in opposing directions, expression of Bcl-3 could not be altered by them(Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="263">
                    <text>Since a mechanism were in opposing directions, expression of Bcl-3 was not able to be altered by them(Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="264">
                    <text>Since a mechanism were in opposing directions, expression of Bcl-3 was not altered by them(Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="265">
                    <text>Since a mechanism were in opposing directions, they could not alter expression of Bcl-3(Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="266">
                    <text>Since a mechanism were in opposing directions, they did not alter expression of Bcl-3(Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="267">
                    <text>Since a mechanism were in opposing directions, they were not able to alter expression of Bcl-3(Figure 3C).</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="268">
                    <text>Since s1031 is a null allele, we are testing whether Dam methylation can alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="269">
                    <text>Since s1031 is a null allele, we are testing whether Dam methylation is able to alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="270">
                    <text>Since s1031 is a null allele, we are testing whether Dam methylation is going to alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="271">
                    <text>Since s1031 is a null allele, we are testing whether Dam methylation may alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="272">
                    <text>Since s1031 is a null allele, we are testing whether Dam methylation will alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="273">
                    <text>Since s1031 is a null allele, we are testing whether Four other mutations can alter either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="274">
                    <text>Since s1031 is a null allele, we are testing whether Four other mutations is able to alter either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="275">
                    <text>Since s1031 is a null allele, we are testing whether Four other mutations is going to alter either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="276">
                    <text>Since s1031 is a null allele, we are testing whether Four other mutations may alter either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="277">
                    <text>Since s1031 is a null allele, we are testing whether Four other mutations will alter either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="278">
                    <text>Since s1031 is a null allele, we are testing whether Mutations can alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="279">
                    <text>Since s1031 is a null allele, we are testing whether Mutations is able to alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="280">
                    <text>Since s1031 is a null allele, we are testing whether Mutations is going to alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="281">
                    <text>Since s1031 is a null allele, we are testing whether Mutations may alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="282">
                    <text>Since s1031 is a null allele, we are testing whether Mutations will alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="283">
                    <text>Since s1031 is a null allele, we are testing whether Phosphorylation of PDK1 can be altered by treating the cells with insulin-like growth factor-I.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="284">
                    <text>Since s1031 is a null allele, we are testing whether Phosphorylation of PDK1 is able to be altered by treating the cells with insulin-like growth factor-I.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="285">
                    <text>Since s1031 is a null allele, we are testing whether Phosphorylation of PDK1 is altered by treating the cells with insulin-like growth factor-I.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="286">
                    <text>Since s1031 is a null allele, we are testing whether Phosphorylation of PDK1 may be altered by treating the cells with insulin-like growth factor-I.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="287">
                    <text>Since s1031 is a null allele, we are testing whether a mechanism can alter expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="288">
                    <text>Since s1031 is a null allele, we are testing whether a mechanism is able to alter expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="289">
                    <text>Since s1031 is a null allele, we are testing whether a mechanism is going to alter expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="290">
                    <text>Since s1031 is a null allele, we are testing whether a mechanism may alter expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="291">
                    <text>Since s1031 is a null allele, we are testing whether a mechanism will alter expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="292">
                    <text>Since s1031 is a null allele, we are testing whether binding of Lrp at the GATC1130 site can be altered by Dam methylation.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="293">
                    <text>Since s1031 is a null allele, we are testing whether binding of Lrp at the GATC1130 site is able to be altered by Dam methylation.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="294">
                    <text>Since s1031 is a null allele, we are testing whether binding of Lrp at the GATC1130 site is altered by Dam methylation.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="295">
                    <text>Since s1031 is a null allele, we are testing whether binding of Lrp at the GATC1130 site may be altered by Dam methylation.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="296">
                    <text>Since s1031 is a null allele, we are testing whether either the conserved gt or ag dinucleotide splice sites can be altered by Four other mutations.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="297">
                    <text>Since s1031 is a null allele, we are testing whether either the conserved gt or ag dinucleotide splice sites is able to be altered by Four other mutations.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="298">
                    <text>Since s1031 is a null allele, we are testing whether either the conserved gt or ag dinucleotide splice sites is altered by Four other mutations.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="299">
                    <text>Since s1031 is a null allele, we are testing whether either the conserved gt or ag dinucleotide splice sites may be altered by Four other mutations.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="300">
                    <text>Since s1031 is a null allele, we are testing whether expression of Bcl-3 can be altered by a mechanism.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="301">
                    <text>Since s1031 is a null allele, we are testing whether expression of Bcl-3 is able to be altered by a mechanism.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="302">
                    <text>Since s1031 is a null allele, we are testing whether expression of Bcl-3 is altered by a mechanism.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="303">
                    <text>Since s1031 is a null allele, we are testing whether expression of Bcl-3 may be altered by a mechanism.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="304">
                    <text>Since s1031 is a null allele, we are testing whether splice variations can alter the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="305">
                    <text>Since s1031 is a null allele, we are testing whether splice variations is able to alter the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="306">
                    <text>Since s1031 is a null allele, we are testing whether splice variations is going to alter the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="307">
                    <text>Since s1031 is a null allele, we are testing whether splice variations may alter the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="308">
                    <text>Since s1031 is a null allele, we are testing whether splice variations will alter the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="309">
                    <text>Since s1031 is a null allele, we are testing whether splicing can be altered by the molecular lesion associated with s1031.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="310">
                    <text>Since s1031 is a null allele, we are testing whether splicing is able to be altered by the molecular lesion associated with s1031.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="311">
                    <text>Since s1031 is a null allele, we are testing whether splicing is altered by the molecular lesion associated with s1031.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="312">
                    <text>Since s1031 is a null allele, we are testing whether splicing may be altered by the molecular lesion associated with s1031.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="313">
                    <text>Since s1031 is a null allele, we are testing whether the molecular lesion associated with s1031 can alter splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="314">
                    <text>Since s1031 is a null allele, we are testing whether the molecular lesion associated with s1031 is able to alter splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="315">
                    <text>Since s1031 is a null allele, we are testing whether the molecular lesion associated with s1031 is going to alter splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="316">
                    <text>Since s1031 is a null allele, we are testing whether the molecular lesion associated with s1031 may alter splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="317">
                    <text>Since s1031 is a null allele, we are testing whether the molecular lesion associated with s1031 will alter splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="318">
                    <text>Since s1031 is a null allele, we are testing whether the phasing of the binding sites can be altered by Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="319">
                    <text>Since s1031 is a null allele, we are testing whether the phasing of the binding sites is able to be altered by Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="320">
                    <text>Since s1031 is a null allele, we are testing whether the phasing of the binding sites is altered by Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="321">
                    <text>Since s1031 is a null allele, we are testing whether the phasing of the binding sites may be altered by Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="322">
                    <text>Since s1031 is a null allele, we are testing whether the protein product can be altered by splice variations.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="323">
                    <text>Since s1031 is a null allele, we are testing whether the protein product is able to be altered by splice variations.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="324">
                    <text>Since s1031 is a null allele, we are testing whether the protein product is altered by splice variations.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="325">
                    <text>Since s1031 is a null allele, we are testing whether the protein product may be altered by splice variations.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="326">
                    <text>Since s1031 is a null allele, we are testing whether treating the cells with insulin-like growth factor-I can alter Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="327">
                    <text>Since s1031 is a null allele, we are testing whether treating the cells with insulin-like growth factor-I is able to alter Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="328">
                    <text>Since s1031 is a null allele, we are testing whether treating the cells with insulin-like growth factor-I is going to alter Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="329">
                    <text>Since s1031 is a null allele, we are testing whether treating the cells with insulin-like growth factor-I may alter Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="330">
                    <text>Since s1031 is a null allele, we are testing whether treating the cells with insulin-like growth factor-I will alter Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="331">
                    <text>Since s1031 is a null allele, we tested whether Dam methylation altered binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="332">
                    <text>Since s1031 is a null allele, we tested whether Dam methylation alters binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="333">
                    <text>Since s1031 is a null allele, we tested whether Dam methylation could alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="334">
                    <text>Since s1031 is a null allele, we tested whether Dam methylation has altered binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="335">
                    <text>Since s1031 is a null allele, we tested whether Dam methylation might alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="336">
                    <text>Since s1031 is a null allele, we tested whether Dam methylation was able to alter binding of Lrp at the GATC1130 site.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="337">
                    <text>Since s1031 is a null allele, we tested whether Four other mutations altered either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="338">
                    <text>Since s1031 is a null allele, we tested whether Four other mutations alters either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="339">
                    <text>Since s1031 is a null allele, we tested whether Four other mutations could alter either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="340">
                    <text>Since s1031 is a null allele, we tested whether Four other mutations has altered either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="341">
                    <text>Since s1031 is a null allele, we tested whether Four other mutations might alter either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="342">
                    <text>Since s1031 is a null allele, we tested whether Four other mutations was able to alter either the conserved gt or ag dinucleotide splice sites.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="343">
                    <text>Since s1031 is a null allele, we tested whether Mutations altered the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="344">
                    <text>Since s1031 is a null allele, we tested whether Mutations alters the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="345">
                    <text>Since s1031 is a null allele, we tested whether Mutations could alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="346">
                    <text>Since s1031 is a null allele, we tested whether Mutations has altered the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="347">
                    <text>Since s1031 is a null allele, we tested whether Mutations might alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="348">
                    <text>Since s1031 is a null allele, we tested whether Mutations was able to alter the phasing of the binding sites.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="349">
                    <text>Since s1031 is a null allele, we tested whether Phosphorylation of PDK1 could be altered by treating the cells with insulin-like growth factor-I.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="350">
                    <text>Since s1031 is a null allele, we tested whether Phosphorylation of PDK1 might be altered by treating the cells with insulin-like growth factor-I.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="351">
                    <text>Since s1031 is a null allele, we tested whether Phosphorylation of PDK1 was able to be altered by treating the cells with insulin-like growth factor-I.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="352">
                    <text>Since s1031 is a null allele, we tested whether Phosphorylation of PDK1 was altered by treating the cells with insulin-like growth factor-I.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="353">
                    <text>Since s1031 is a null allele, we tested whether a mechanism altered expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="354">
                    <text>Since s1031 is a null allele, we tested whether a mechanism alters expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="355">
                    <text>Since s1031 is a null allele, we tested whether a mechanism could alter expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="356">
                    <text>Since s1031 is a null allele, we tested whether a mechanism has altered expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="357">
                    <text>Since s1031 is a null allele, we tested whether a mechanism might alter expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="358">
                    <text>Since s1031 is a null allele, we tested whether a mechanism was able to alter expression of Bcl-3.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="359">
                    <text>Since s1031 is a null allele, we tested whether binding of Lrp at the GATC1130 site could be altered by Dam methylation.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="360">
                    <text>Since s1031 is a null allele, we tested whether binding of Lrp at the GATC1130 site might be altered by Dam methylation.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="361">
                    <text>Since s1031 is a null allele, we tested whether binding of Lrp at the GATC1130 site was able to be altered by Dam methylation.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="362">
                    <text>Since s1031 is a null allele, we tested whether binding of Lrp at the GATC1130 site was altered by Dam methylation.</text>
                    <arg n="0">Dam methylation</arg>
                    <arg n="1">binding of Lrp at the GATC1130 site</arg>
                </example>
                <example src="REPLACE" no="363">
                    <text>Since s1031 is a null allele, we tested whether either the conserved gt or ag dinucleotide splice sites could be altered by Four other mutations.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="364">
                    <text>Since s1031 is a null allele, we tested whether either the conserved gt or ag dinucleotide splice sites might be altered by Four other mutations.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="365">
                    <text>Since s1031 is a null allele, we tested whether either the conserved gt or ag dinucleotide splice sites was able to be altered by Four other mutations.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="366">
                    <text>Since s1031 is a null allele, we tested whether either the conserved gt or ag dinucleotide splice sites was altered by Four other mutations.</text>
                    <arg n="0">Four other mutations</arg>
                    <arg n="1">either the conserved gt or ag dinucleotide splice sites</arg>
                </example>
                <example src="REPLACE" no="367">
                    <text>Since s1031 is a null allele, we tested whether expression of Bcl-3 could be altered by a mechanism.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="368">
                    <text>Since s1031 is a null allele, we tested whether expression of Bcl-3 might be altered by a mechanism.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="369">
                    <text>Since s1031 is a null allele, we tested whether expression of Bcl-3 was able to be altered by a mechanism.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="370">
                    <text>Since s1031 is a null allele, we tested whether expression of Bcl-3 was altered by a mechanism.</text>
                    <arg n="0">a mechanism</arg>
                    <arg n="1">expression of Bcl-3</arg>
                </example>
                <example src="REPLACE" no="371">
                    <text>Since s1031 is a null allele, we tested whether splice variations altered the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="372">
                    <text>Since s1031 is a null allele, we tested whether splice variations alters the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="373">
                    <text>Since s1031 is a null allele, we tested whether splice variations could alter the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="374">
                    <text>Since s1031 is a null allele, we tested whether splice variations has altered the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="375">
                    <text>Since s1031 is a null allele, we tested whether splice variations might alter the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="376">
                    <text>Since s1031 is a null allele, we tested whether splice variations was able to alter the protein product.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="377">
                    <text>Since s1031 is a null allele, we tested whether splicing could be altered by the molecular lesion associated with s1031.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="378">
                    <text>Since s1031 is a null allele, we tested whether splicing might be altered by the molecular lesion associated with s1031.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="379">
                    <text>Since s1031 is a null allele, we tested whether splicing was able to be altered by the molecular lesion associated with s1031.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="380">
                    <text>Since s1031 is a null allele, we tested whether splicing was altered by the molecular lesion associated with s1031.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="381">
                    <text>Since s1031 is a null allele, we tested whether the molecular lesion associated with s1031 altered splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="382">
                    <text>Since s1031 is a null allele, we tested whether the molecular lesion associated with s1031 alters splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="383">
                    <text>Since s1031 is a null allele, we tested whether the molecular lesion associated with s1031 could alter splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="384">
                    <text>Since s1031 is a null allele, we tested whether the molecular lesion associated with s1031 has altered splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="385">
                    <text>Since s1031 is a null allele, we tested whether the molecular lesion associated with s1031 might alter splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="386">
                    <text>Since s1031 is a null allele, we tested whether the molecular lesion associated with s1031 was able to alter splicing.</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="387">
                    <text>Since s1031 is a null allele, we tested whether the phasing of the binding sites could be altered by Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="388">
                    <text>Since s1031 is a null allele, we tested whether the phasing of the binding sites might be altered by Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="389">
                    <text>Since s1031 is a null allele, we tested whether the phasing of the binding sites was able to be altered by Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="390">
                    <text>Since s1031 is a null allele, we tested whether the phasing of the binding sites was altered by Mutations.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="1">the phasing of the binding sites</arg>
                </example>
                <example src="REPLACE" no="391">
                    <text>Since s1031 is a null allele, we tested whether the protein product could be altered by splice variations.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="392">
                    <text>Since s1031 is a null allele, we tested whether the protein product might be altered by splice variations.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="393">
                    <text>Since s1031 is a null allele, we tested whether the protein product was able to be altered by splice variations.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="394">
                    <text>Since s1031 is a null allele, we tested whether the protein product was altered by splice variations.</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="395">
                    <text>Since s1031 is a null allele, we tested whether treating the cells with insulin-like growth factor-I altered Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="396">
                    <text>Since s1031 is a null allele, we tested whether treating the cells with insulin-like growth factor-I alters Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="397">
                    <text>Since s1031 is a null allele, we tested whether treating the cells with insulin-like growth factor-I could alter Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="398">
                    <text>Since s1031 is a null allele, we tested whether treating the cells with insulin-like growth factor-I has altered Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="399">
                    <text>Since s1031 is a null allele, we tested whether treating the cells with insulin-like growth factor-I might alter Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="400">
                    <text>Since s1031 is a null allele, we tested whether treating the cells with insulin-like growth factor-I was able to alter Phosphorylation of PDK1.</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="401">
                    <text>Since splice variations are in opposing directions, the protein product cannot be altered by them(Figure 3C).</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="402">
                    <text>Since splice variations are in opposing directions, the protein product is not able to be altered by them(Figure 3C).</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="403">
                    <text>Since splice variations are in opposing directions, the protein product is not altered by them(Figure 3C).</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="404">
                    <text>Since splice variations are in opposing directions, the protein product may not be altered by them(Figure 3C).</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="405">
                    <text>Since splice variations are in opposing directions, the protein product will not be altered by them(Figure 3C).</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="406">
                    <text>Since splice variations are in opposing directions, they are not able to alter the protein product(Figure 3C).</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="407">
                    <text>Since splice variations are in opposing directions, they cannot alter the protein product(Figure 3C).</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="408">
                    <text>Since splice variations are in opposing directions, they do not alter the protein product(Figure 3C).</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="409">
                    <text>Since splice variations are in opposing directions, they may not alter the protein product(Figure 3C).</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="410">
                    <text>Since splice variations are in opposing directions, they will not alter the protein product(Figure 3C).</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="411">
                    <text>Since splice variations were in opposing directions, the protein product could not be altered by them(Figure 3C).</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="412">
                    <text>Since splice variations were in opposing directions, the protein product was not able to be altered by them(Figure 3C).</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="413">
                    <text>Since splice variations were in opposing directions, the protein product was not altered by them(Figure 3C).</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="414">
                    <text>Since splice variations were in opposing directions, they could not alter the protein product(Figure 3C).</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="415">
                    <text>Since splice variations were in opposing directions, they did not alter the protein product(Figure 3C).</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="416">
                    <text>Since splice variations were in opposing directions, they were not able to alter the protein product(Figure 3C).</text>
                    <arg n="0">splice variations</arg>
                    <arg n="1">the protein product</arg>
                </example>
                <example src="REPLACE" no="417">
                    <text>Since the molecular lesion associated with s1031 are in opposing directions, splicing cannot be altered by them(Figure 3C).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="418">
                    <text>Since the molecular lesion associated with s1031 are in opposing directions, splicing is not able to be altered by them(Figure 3C).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="419">
                    <text>Since the molecular lesion associated with s1031 are in opposing directions, splicing is not altered by them(Figure 3C).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="420">
                    <text>Since the molecular lesion associated with s1031 are in opposing directions, splicing may not be altered by them(Figure 3C).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="421">
                    <text>Since the molecular lesion associated with s1031 are in opposing directions, splicing will not be altered by them(Figure 3C).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="422">
                    <text>Since the molecular lesion associated with s1031 are in opposing directions, they are not able to alter splicing(Figure 3C).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="423">
                    <text>Since the molecular lesion associated with s1031 are in opposing directions, they cannot alter splicing(Figure 3C).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="424">
                    <text>Since the molecular lesion associated with s1031 are in opposing directions, they do not alter splicing(Figure 3C).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="425">
                    <text>Since the molecular lesion associated with s1031 are in opposing directions, they may not alter splicing(Figure 3C).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="426">
                    <text>Since the molecular lesion associated with s1031 are in opposing directions, they will not alter splicing(Figure 3C).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="427">
                    <text>Since the molecular lesion associated with s1031 were in opposing directions, splicing could not be altered by them(Figure 3C).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="428">
                    <text>Since the molecular lesion associated with s1031 were in opposing directions, splicing was not able to be altered by them(Figure 3C).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="429">
                    <text>Since the molecular lesion associated with s1031 were in opposing directions, splicing was not altered by them(Figure 3C).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="430">
                    <text>Since the molecular lesion associated with s1031 were in opposing directions, they could not alter splicing(Figure 3C).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="431">
                    <text>Since the molecular lesion associated with s1031 were in opposing directions, they did not alter splicing(Figure 3C).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="432">
                    <text>Since the molecular lesion associated with s1031 were in opposing directions, they were not able to alter splicing(Figure 3C).</text>
                    <arg n="0">the molecular lesion associated with s1031</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="433">
                    <text>Since treating the cells with insulin-like growth factor-I are in opposing directions, Phosphorylation of PDK1 cannot be altered by them(Figure 3C).</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="434">
                    <text>Since treating the cells with insulin-like growth factor-I are in opposing directions, Phosphorylation of PDK1 is not able to be altered by them(Figure 3C).</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="435">
                    <text>Since treating the cells with insulin-like growth factor-I are in opposing directions, Phosphorylation of PDK1 is not altered by them(Figure 3C).</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="436">
                    <text>Since treating the cells with insulin-like growth factor-I are in opposing directions, Phosphorylation of PDK1 may not be altered by them(Figure 3C).</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="437">
                    <text>Since treating the cells with insulin-like growth factor-I are in opposing directions, Phosphorylation of PDK1 will not be altered by them(Figure 3C).</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="438">
                    <text>Since treating the cells with insulin-like growth factor-I are in opposing directions, they are not able to alter Phosphorylation of PDK1(Figure 3C).</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="439">
                    <text>Since treating the cells with insulin-like growth factor-I are in opposing directions, they cannot alter Phosphorylation of PDK1(Figure 3C).</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="440">
                    <text>Since treating the cells with insulin-like growth factor-I are in opposing directions, they do not alter Phosphorylation of PDK1(Figure 3C).</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="441">
                    <text>Since treating the cells with insulin-like growth factor-I are in opposing directions, they may not alter Phosphorylation of PDK1(Figure 3C).</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="442">
                    <text>Since treating the cells with insulin-like growth factor-I are in opposing directions, they will not alter Phosphorylation of PDK1(Figure 3C).</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="443">
                    <text>Since treating the cells with insulin-like growth factor-I were in opposing directions, Phosphorylation of PDK1 could not be altered by them(Figure 3C).</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="444">
                    <text>Since treating the cells with insulin-like growth factor-I were in opposing directions, Phosphorylation of PDK1 was not able to be altered by them(Figure 3C).</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="445">
                    <text>Since treating the cells with insulin-like growth factor-I were in opposing directions, Phosphorylation of PDK1 was not altered by them(Figure 3C).</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="446">
                    <text>Since treating the cells with insulin-like growth factor-I were in opposing directions, they could not alter Phosphorylation of PDK1(Figure 3C).</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="447">
                    <text>Since treating the cells with insulin-like growth factor-I were in opposing directions, they did not alter Phosphorylation of PDK1(Figure 3C).</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
                <example src="REPLACE" no="448">
                    <text>Since treating the cells with insulin-like growth factor-I were in opposing directions, they were not able to alter Phosphorylation of PDK1(Figure 3C).</text>
                    <arg n="0">treating the cells with insulin-like growth factor-I</arg>
                    <arg n="1">Phosphorylation of PDK1</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
